Higher plasma levels of lysophosphatidylcholine 18:0 are related to a lower risk of common cancers in a prospective metabolomics study
about
Maternal cytokine status may prime the metabolic profile and increase risk for obesity in children.Pre-diagnostic metabolite concentrations and prostate cancer risk in 1077 cases and 1077 matched controls in the European Prospective Investigation into Cancer and Nutrition.Anti-melanoma activity of Forsythiae Fructus aqueous extract in mice involves regulation of glycerophospholipid metabolisms by UPLC/Q-TOF MS-based metabolomics study.Is it possible to detect PEth 16:0/18:1 and PEth 18:1/18:1 in red blood cells after 20 years of storage in liquid nitrogen?Monitoring cancer prognosis, diagnosis and treatment efficacy using metabolomics and lipidomics.The molecular mechanism by which saturated lysophosphatidylcholine attenuates the metastatic capacity of melanoma cells.Identification of the lipid biomarkers from plasma in idiopathic pulmonary fibrosis by Lipidomics.Serum metabolites and risk of myocardial infarction and ischemic stroke: a targeted metabolomic approach in two German prospective cohorts.Reduced levels of N'-methyl-2-pyridone-5-carboxamide and lysophosphatidylcholine 16:0 in the serum of patients with intrahepatic cholangiocarcinoma, and the correlation with recurrence-free survival.Plasma Lipidomic Signature of Rectal Adenocarcinoma Reveals Potential Biomarkers.Metabolomics toward personalized medicine.Metabolomic profiles in breast cancer:a pilot case-control study in the breast cancer family registry.Individualized metabolic profiling stratifies pancreatic and biliary tract cancer: a useful tool for innovative screening programs and predictive strategies in healthcareDietary stearic acid regulates mitochondria in vivo in humans
P2860
Q30313189-2B1A62CC-3472-4357-B362-C8E661D77B3EQ33872077-A6F90BB0-2ED1-4FC3-A8D9-8CD2F86A9DF5Q37519196-7CD1628C-B24C-476C-AF7D-98F8050788B6Q38710297-D86A2646-5EE2-492B-A537-1829BF4BF4B3Q38822368-F8A7528A-68E9-4954-8E61-022E375C1535Q42201053-70862287-9981-48B2-928D-A77EA1F9EA44Q46246621-7D301B13-A2F6-44B3-8903-4A9E04C17DD1Q47357441-9DC7A594-77DD-4987-A050-759D4D850844Q47559129-1DF65271-8160-438B-9016-DAE5CAD43553Q48527663-1BC8F027-29CD-4CDF-B754-4E0114A776CCQ50090010-F549D4D0-80E1-4434-AB71-F75524F29321Q55216953-383AC519-AAE4-429F-BB03-85B02F413D15Q58769747-AE3A9BB0-2C5E-42CA-B57A-EC8EE623F4B0Q58797795-61F6CBD7-F8C5-4941-9E50-AB1313015F2F
P2860
Higher plasma levels of lysophosphatidylcholine 18:0 are related to a lower risk of common cancers in a prospective metabolomics study
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Higher plasma levels of lysoph ...... prospective metabolomics study
@ast
Higher plasma levels of lysoph ...... prospective metabolomics study
@en
type
label
Higher plasma levels of lysoph ...... prospective metabolomics study
@ast
Higher plasma levels of lysoph ...... prospective metabolomics study
@en
prefLabel
Higher plasma levels of lysoph ...... prospective metabolomics study
@ast
Higher plasma levels of lysoph ...... prospective metabolomics study
@en
P2093
P2860
P50
P1433
P1476
Higher plasma levels of lysoph ...... prospective metabolomics study
@en
P2093
Disorn Sookthai
Martin von Bergen
Theron Johnson
Tilman Kühn
Wolfgang Otto
P2860
P2888
P356
10.1186/S12916-016-0552-3
P407
P577
2016-01-28T00:00:00Z